Healthy and Unhealthy Gut Bacteria

Since the January 10, 2014 posting, Psych Central: “Antibodies in GI Tract Linked to Greater Risk for Bipolar Illness”, research on gut bacteria has increased exponentially regarding how good bacteria plays a positive role for the mind and body, and in particular cognitive difficulties that can manifest from unhealthy bacteria.  The following are links for additional literature concerning both kinds of bacteria:

 

Microbes Help Produce Serotonin in Gut (California Institute of Technology (Caltech.edu), April 9, 2015)

Immune system uses gut bacteria to control glucose metabolism (Science Daily, November 14, 2016)

Gut microbiome contributes to Parkinson’s, study suggests (MedicalNewsToday.com, December 2, 2016)

Likely Connection Between Obsessive-Compulsive Disorder and the Gut Microbiome (Psychiatry Advisor, May 17, 2016)

The Gastrointestinal Tract Microbiome and Potential Link to Alzheimer’s Disease (US National Library of Medicine, National Institutes of Health – Frontiers in Neurology, April 4, 2014)

The tantalizing links between gut microbes and the brain (Nature, International Weekly Journal of Science, October 16, 2015)

 

The following resource is a brief presentation by Dr. Samuel Hunter:

[VIDEO] “Gut Bacteria and Multiple Sclerosis”

 

 

Vikki

 

 

Psychiatric Medications and the Youth Population*

imageimageimage

While psychiatric medicines such as Lithium, Abilify and Risperidone exist designed specifically for younger consumers, pharmaceuticals need to create safer ones.  A young person’s brain isn’t fully developed until their early twenties.  The body as a whole should have the capacity to withstand medications. Presently, many youth experience toxicity, weakened bones, and neurological challenges from appropriate drug usage.  Kidney damage, at times irreversible, is one of the consequences from Lithium.

All medications have side effects and not every user will experience them.  However, side effects associated with psychotropic drugs can be greatly reduced with newer medicines targeted for this segment of the population.

*First-generation psychiatric drugs went on the market before the late 1980’s. These medications can result in neurological problems.  Second generation psychiatric drugs went on the market after the late 1980’s. These medications can result in weight gain, diabetes, elevated levels of cholesterol, and neurological problems. 

Vikki